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1. Introduction 
Telemedicine system is defined as the use of tele-communications to support health care 
with the purpose to facilitate the interaction between patient and health care provider and to 
achieve improved treatment results and lower treatment costs. This approach, currently 
spreading, is becoming a useful mean to ensure home health care, remote patient 
monitoring and disease management. Furthermore, telemedicine can support educational 
and training programs for patients and health care providers. Technological innovation in 
medical care and introduction of telecommunication technologies in medical practice have 
led to the development of telemedicine programs in many medical specialities. The principal 
aims of a telemedicine system applied to clinical practice are to improve health care and 
social assistance. The concept of telemedicine in Oral Anticoagulant Therapy (OAT) 
management grows from the necessity to improve interactions between patients and health 
care providers and, at the same time, to enhance management system. The increase of 
communication requests among different subjects can be facilitated through the elaboration 
of data networks between the Anticoagulation Clinic (AC), general practitioner or other 
peripheral districts and patients. Telemedicine systems for OAT have been developed 
during the last few years with the aim to decentralize in the health territorial care units the 
activity of ACs, improving the quality of life of the patients living far from the AC site and 
maintaining the same clinical quality levels. A telemedicine system for anticoagulated 
patients should be structured through net supported programs (intra and internet) to collect 
and elaborate clinical data, connected among hospital divisions, health care peripheral 
districts and  patients. A digital format to collect clinical data, an electronic medical record, 
communication tools to connect patients and peripheral health care and a global quality 
control system are mandatory requirements to set up a telemedicine system. All 
communications, including clinical data, laboratory controls, alerts, prescriptions and 
recommendations have to be available in real time through a bi-directional connection. The 
telematic organization could develop different types of solutions for different types of 
patients in OAT population. For example:  
 independent patient, who lives far away from the Clinic but can reach a peripheral 
district (Hospice, General Practitioner and so on);   
 home patient not independent;   
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 totally independent patient. 
From a general point of view, new web telematic organizations can provide several 
advantages in comparison with standard treatments, with the principal aim to improve 
patient management, as , for, example:  
 direct communication between districts and AC; 
 good or improved clinical quality (time spent in the therapeutic range and major 
complications);  
 improvement in patient’s satisfaction and in their quality of life;  
 continuing medical record update;  
 time gained by staff; 
 possibility to manage different antithrombotic drugs (heparins and new oral 
anticoagulant agents). 
2. Antivitamin K antagonists 
In this chapter we will refer to OAT considering only Anti-vitamin K antagonists (AVK). 
The new oral anticoagulant drugs, very recently approved, are prescribed only in few 
countries all over the world and insufficient information on types of management are 
available at present. AVK are very effective drugs in many clinical conditions such as deep 
venous thrombosis, pulmonary embolism, atrial fibrillation, prostheses heart valve, 
myocardial infarction and cardioembolic ischemic stroke. AVK as oral anticoagulation 
therapy (OAT) are life-saving therapies that can effectively prevent cardioembolic strokes 
related to atrial fibrillation and heart valve replacements, treat venous thromboembolism, 
with a relative low risk of major bleeding complications. Because of their characteristics, still 
at present, AVK are under/and sub-optimal used and consequently their maximum efficacy 
is not still reached in the real world patient population. As well known, the major incidence  
of thromboembolic or haemorragic events occurs when the prothrombin time (PT), 
expressed as the international normalized ratio (INR), is out of the therapeutic range.  
Therefore effectiveness and safety of OAT increase when a good control of anticoagulation 
level is guaranteed. For this reason, a correct use of AVK requires a careful clinical and 
laboratory monitoring, as well as specific competences for managing the possible 
complications and/or emergencies (Ansell et al., 2008). The risk of thrombosis increases 
with age and the progressive ageing of the population causes a constant increase of patients 
who need OAT as consequence. For this reason, during the last 15 years, patients on AVK 
are constantly increasing and results coming from unofficial data show about 1.000.000 
patients in Italy, with a prevalence that is 1.6% of the total population (Fig. 1). Vitamin K 
antagonists determine their anticoagulant effect by interfering with the metabolism of 
vitamin K.  In Italy two different types of coumarins are available, warfarin (Coumadin) and 
acenocoumarol (Sintrom) which differ because of their half-life, that is longer for warfarin 
(36-42 vs 12-16 hours), the most prescribed drug in Italy at present. Warfarin has high 
bioavailability and is rapidly absorbed from the gastrointestinal tract; the maximal blood 
concentration is reached 90 minutes after oral administration. Coumarins in the blood are 
bound to plasma proteins (principally albumin) and accumulated in the liver, where they 
act through the inhibition of vitamin K epoxide reductase enzyme (Fig. 2).  
The high inter and intra-individual biological variability is one the main problem in AVK 
management, principally due to genetic conditions, drug absorption, drug interferences, 
diet and co-morbidities (Feero, Guttmacher, 2011). On this basis many anticoagulation 
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clinics (AC) have been set up in Italy, operating in the framework of the Italian Federation of 
Anticoagulation Clinics (FCSA) (Fig. 3).  
 
 
 
 
Fig. 1. Increase of patients on AVK in Italy 
 
 
 
 
 
 
 
Fig. 2. Warfarin and vitamin K cycles 
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Fig. 3. Italian Federation of Anticoagulation Clinics (FCSA): ACs distribution 
Compliance of patients that require long-term therapy is a crucial problem and represents 
an important factor of variability of both quality of treatment and patient management.  In 
fact, as shown in literature, patients on chronic therapy omit about 40% of their daily 
medications and 10-26% of the patients on chronic OAT are not compliant (Barcellona et al., 
2002). As a consequence, poor compliance is associated to bad quality treatment. 
Educational courses for patients (indications for treatment, risk and benefit, problem in drug 
administration, dietary behaviour, interactions with other drugs and intercurrent disease) 
and for health territorial care units can improve patient's compliance (Barcellona et al., 
2002). Telemedicine systems can empower educational programs with the aim to  improve 
drug adherences, increase interactions between OAT patients and health care organizations. 
Taking into consideration economical and clinical advantages provided by AC, compared to 
other types of management (see paragraph 3.3), the decentralization into peripheral health 
units using telemedicine systems, represents an effective evolution of the management 
strategies. 
3. Model of management 
3.1 Type of management 
As for all pharmacological treatments even for AVK, three crucial points should be 
considered to define not only the correct drug indications but also risks and advantages. In 
synthesis before starting anticoagulation we should answer to the following questions: 
 is OAT indicated on that clinical condition ? (= treatment effectiveness); 
 is there an increase of benefit compared to OAT risk? (= treatment safety); 
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 which is the appropriate management model ?(= type of patient management). 
The growth of OAT population recorded in the past twenty years is undoubtedly related to 
many factors, including the organization of Anticoagulation Clinics (AC) and the 
standardisation of laboratory methods, which has allowed to perform clinical trials in order 
to demonstrate OAT efficacy and safety (Bussey et al., 1989). These studies have supplied a 
better knowledge of therapeutic indications, optimal anticoagulation levels (therapeutic 
ranges), risk of haemorrhagic and thrombotic complications, pharmacological interference 
and the importance of a specialistic management (Charney et al., 1988). However, in daily 
clinical practice OAT is still underused because often considered by the medical class itself 
as a therapy that can be hardly managed, laborious and potentially dangerous for the 
patient, and a certain number of patients self-prescribe without specific training with serious 
risks for their health. We can consider 4 different management models: 1) routine medical 
care (RMC), 2) AC, 3) patient self testing and 4) patient self management. The four models 
for OAT control are variously developed in different countries. The model prevailing in the 
United States is the Usual Care (UC), in which patients refer directly to their own general 
practitioner or specialist; the INR is determined in external laboratories or in general 
practitioner’s consulting room through portable monitors. In countries such as England, 
Holland, Italy and Spain, Anticoagulation Clinics (AC) are developed. ACs can interact with 
the general practitioners on various levels, according to their competence. In particular, ACs 
have been set up in Italy in order to: 
 determine the appropriate clinical indications for anticoagulant treatment; 
 determine the laboratory tests necessary for pharmacological monitoring; 
 prescribe the anticoagulation regimen based on the results of the laboratory tests; 
 define intervals for regular anticoagulation controls; 
 evaluate any potential pharmacological interference;  
 take care of patients undergoing surgical interventions or invasive procedures; 
 manage the patients during intercurrent diseases; 
 hold training courses and educational programs for patients and healthcare providers.  
Several studies have shown that anticoagulation management is crucial to ensure quality of 
treatment and, among different types of management, Anticoagulation Clinic (AC) results in 
better clinical control compared with routine medical care (RMC) (Bussey et al. 1996; 
Chiquette et al. 1998).   
3.2 Patient self testing and patient self management  
New technologies applied to INR testing determined the development of portable 
coagulometers. Portable monitors are small, handy instruments, easy to transport and allow 
PT/INR testing with a drop of whole blood. The widespread use of portable monitors in 
clinical practice allowed the development of point of care testing, shifting the analytical 
phase from the laboratory to patient with considerable advantage in terms of convenience 
and comfort for the patient. Those systems are very useful to manage patients at home or at 
peripheral health care units (nursing homes, groups of general practitioners, health 
communities), simplifying and improving OAT management. OAT self monitoring through 
portable coagulometers has the potential advantage to be easy to use for the patient or 
caregivers and potentially improve patient’s quality of life (Tripodi et al. 1993). There are 
several ways for using portable coagulometers that we can summarize as self-testing (PST) 
and self-management (PSM). With PST the patient autonomously monitors his/her own 
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PT/INR using portable coagulometer, living OAT decision to AC. Self-testing therefore 
offers the patient the opportunity of increasing test frequency (Watzke et al., 2000). With 
PSM the patient not only monitors his/her own PT/INR but also self-prescribes drug 
dosage. As shown in literature self-testing and self-management leads to a significant 50% 
reduction in thromboembolism and 13% reduction in major haemorrhage, compared to 
RMC (Fitzmaurice et al., 2005; Sawicki et al., 1999). A recent Cochrane review analyzed 18 
randomized trials, including 4723 patients, to compare PSM vs RMC and confirmed an 
advantage for self-management in thrombotic and haemorrhagic complications (RR for 
thrombosis=0.47; RR for bleeding=0.56) (Garcia-Alamino et al., 2010). We have to highlight 
that just a few number of patients, highly selected, has been enrolled in these studies and a 
real clinical advantage of self-management compared with ACs hasn’t been demonstrated 
(Garcia-Alamino et al., 2010; Cromheecke et al., 2000). Several experiences of OAT 
management in peripheral health units, involving general practitioners and nursing homes, 
coordinated by ACs through telemedicine system, have been started in the last years. Aim of 
these projects, as example of virtual “coagulation clinic”, is to facilitate the anticoagulant 
treatment, improving management quality, reducing risk of complications due to 
inadequate monitoring, with a continuos update of clinical data recording. 
3.3 Cost analysis of different management strategies 
In the last few years, we observed an increased interest in define and control health care 
costs.   First Anglo-Saxon countries, in particular the United States, assessed the costs of 
different anticoagulation management, comparing the specialist system (AC) with non 
specialist system (general medical care, including all physicians who manage patients on 
OAT–RMC) (Elston-Lafata et al., 2000). Although several studies have been published on 
bleeding and thrombotic complications on OAT, only few of them have been focused on the 
evaluation of differences between the two management models (RMC/AC) (Bussey et al. 
1996). It should be noted that most of the available data derived from studies on controlled 
population managed by Anticoagulation Clinics, making it difficult to determine the true 
incidence of complications in other management models. In the ISCOAT study, the most 
large, prospective Italian investigation study, including a cohort from 34 ACs, the incidence 
of major bleeding complications was 1.25 for 100 patient-years, whereas the incidence of 
thromboembolic events was 3.5 for 100 patient-years (Palareti el al., 1997). Literature 
analysis showed that patients on RMC had a 2-fold increase (2.5 vs 1.25% patient-years) and 
3-fold increase (10.5 vs 3.5% patient-years) of bleeding and thromboembolic risks, 
respectively, compared to patients followed by AC (Palareti et al., 1996; Palareti et al., 1997) 
(Tab. 1).  
 
COMPLICATION RMC 
(PERCENT P-Y) 
AC 
(PERCENT P-Y) 
OR 
(CI= 95%) 
Major bleeding 2.5 1.25 0.49 (0.31-0.76) 
Thrombosis 10.5 3.5 0.22 (0.13-0.37) 
Table 1. Risk of major bleeding and thrombotic complication in RMC versus AC  
The final result of the analysis, regarding cost of complications (elaborated on the basis of 
the economic values calculated for diagnosis related groups –DRG- of the Lombardy Region 
in Italy) and the cost of management in ACs, showed an advantage for ACs (366,1 € vs 688,5 
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€). In conclusion AC reduces risk of complications and allow to save 322 € per patient per 
year. The superiority of this anticoagulation management model is due to several reasons, 
the most important of which probably are the accurate laboratory control of PT/INR, a 
structured network for the management of emergencies and major and minor complications 
and a general system that guarantees education, communication and patient’s follow-up 
continuously. For all these reasons ACs currently represent the reference standard for OAT 
management and all new management systems, such as patient self testing (PST) and 
patient self management (PSM),  must be compared to ACs to define their global quality 
(Tab. 2, Tab. 3, Tab. 4). In summary: 
 RMC is less expensive, but less effective and safe; 
 AC represents  a very good  model in term of quality of management, but it’s more 
expansive compared with RMC;  
 PSM is effective and safe, but it can be applied only in nearly 25 % of the patient 
population , highly selected and trained;  
 PST represents the best model (increase in Time spent in Range-TTR, but no differences 
in clinical events compared with AC), but it is the most expensive. It represents an 
opportunity to increase frequency of testing. 
 
 
 
 
OD (95% CI) P 
RMC/AC 0.53 (0.29-0.98) 
 
0.03 
RMC/PST 0.19 (0.09-0.39) 
 
<0.01 
RMC/PSM 0.57 (0.32-1.03) 
 
0.04 
AC/PST 0.36 (0.17-0.75) 
 
0.002 
AC/PSM 1.07 (0.58-1.98) 
 
0.07 
PST/PSM 2.2 (1.04-4.72) 
 
0.02 
Table 2. Time spent in range: comparison among different types of OAT management 
 
Economical variables RMC 
(€ PT/Y) 
AC 
(€ PT/Y) 
PST 
(€ PT/Y) 
PSM 
(€ PT/Y) 
Laboratory monitoring 65.7 65.7 250 250 
AC management --- 147.3 147.3 --- 
Warfarin 30.4 30.4 30.4 30.4 
Total 96.7 243.4 331.7 280.4 
Table 3. Cost comparison among different management strategies 
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 RMC AC PSM PST 
CLINICAL QUALITY + ++++ ++++ ++++ 
TTR + +++ +++ ++++ 
ACCESSIBILITY ++++ ++ + ++ 
COSTS + ++ +++ ++++ 
Table 4. Summary of the  characteristics of the different management models 
4. Telemedicine applied to Anticoagulation Clinic 
4.1 Anticoagulation Clinic 
Taking into account both economic and clinical advantages provided by an AC, and also the 
logistic problems, a reorganization plan could be necessary. The most frequent difficulties 
that an AC could face are the following:  
 strong increase in the number of patients within the AC, mainly on long-term 
treatment, without a concomitant development of structures and increase of  health care 
personnel; 
 difficulty for many patients living far from the AC location in reaching the hospital 
clinic as well as the lack of any AC in the peripheral areas; 
 discomfort of patients (and their relatives) due to overcrowding and lack of public 
transportation;  
A telemedicine system offers the opportunity to empower the daily activity, decentralizing 
the management into peripheral health units, using informatic support and bi-directional 
web connection (Gardiner et al., 2006). In particular the aims of a telemedicine 
reorganization could be summarized as follow: 
 reduce the number of patients referring daily to the AC, decentralizing in peripheral 
health units; 
 maintain the same quality levels defined as the time spent in the therapeutic range and 
number of complications; 
 reduce patient’s discomfort; 
 increase the total number of patients with OAT indications, creating a network that 
reaches home and remote patients; 
 send therapy prescription in real time, through the direct communication between the 
Anticoagulation Clinic and peripheral districts;   
Telemedicine reorganizations give opportunities to peripheral health units to provide the 
following services: 
- Anticoagulation testing performed with portable coagulation analysers, assessing the 
prothrombin time (PT) expressed as international normalized ratio (INR); 
- Quality control of the portable coagulation analyzers; 
- Clinical evaluation of patients (concomitant disease, changes in the drug regimen, 
administration of new drugs, potential surgical interventions, planning of specialist 
visits) through the administration of a medical history questionnaire; 
- Real-time data transmission to the AC. 
Bi-directional connection between AC and peripheral districts allow two different 
management levels: 1) treatment prescription and patient management centralized in AC; 2) 
treatment prescription and patient management performed in peripheral health units, 
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referring to AC in case of complications, over/under treatment, surgery, bridging. The AC  
has also organizing and epidemiological functions. The AC should ensure clinical validation 
of the data received,  transmission of therapeutic measures and clinical advices, patient 
management in case of complications and in case of  any  other clinical condition interfering 
with treatment. Through a telemedicine system AC can provide healthcare to both home 
monitored patients and self-managing patients. Home monitored patients, defined as 
patients who cannot leave home due to serious physical illness, documented disease or 
advanced age, are managed by trained staff using mobile monitoring units connected with 
AC. These equipments can perform INR measurement and transmit the clinical data to the 
AC from the patient’s home setting, in order to receive indications for appropriate therapy 
and urgent medical advice. Self-testing patients, defined as stable and trained patients, 
directly communicate with AC using a telemedicine device installed at home. These patients 
are able to perform PT INR on portable monitors and receive therapy prescription from the 
AC through the web. 
4.2 Portable monitor quality control 
In peripheral health units, INR measurement from capillary blood specimens could be 
performed by portable monitors in a quality assurance global system (Marco et al., 2000). 
The PT/INR determination from venous blood specimens, performed in AC’s laboratory, 
could be considered as the reference system. Taking as reference system PT/INR performed 
on central laboratory, the assessment of agreement should be always evaluated both for 
single patients and for the global accuracy. In general, quality control procedures are 
performed on all portable monitors to assess accuracy and efficacy and, because of no 
standardized recommendations are available, some predefined criteria have to be 
established. Based on current guidelines for laboratory QC the following items can be 
applied: 
 PM suitabily: a) precision calculated on normal plasma pool, repeated 10 times, 
acceptable if CV < 5%; b) accuracy, evaluated on 10 pathological specimens with INR < 
4.0, accettable if INR differences < ± 0.5. 
 Intra-assay precision: each PHU elaborates monthly the Lewej-Jennings cards. Internal 
QC, provided by the company, is performed at the beginning of each session and every 
20 samples. A CV between ± 20% is considered acceptable. 
 Quaterly accuracy to assess the agreement between analytical instruments: every 3 
months PT values from  3 venous blood samples of patients with capillary whole blood 
PT values in the low (2.0-3.0), intermediate (3.0-4.0) and high (> 4.0) INR range are 
compared. Differences  0.5 INR are considered acceptable. In case of discrepancies 
between capillary and venous PT values of more than  0.5, the portable monitor is 
replaced. The choice of this cut-off value derived from the fact that a higher value 
would require remarkable adjustments in the therapeutic regimen. 
 External quality assessment (NEQAS): it considers both laboratory data and clinical 
treatment, to assess the accuracy of the global therapeutic management (Kitchen et al., 
2006). 
4.3 Staff training 
All the staff involved in the global patient management (physicians, laboratory technicians, 
nurses) has to be trained through specific educational programs and updating sessions as 
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for example, recommended by the Italian Federation of Anticoagulation Clinics (FCSA). The 
program should include educational courses on OAT, dedicated courses on the use of 
portable monitors and training on computer programs (Sawicki et al., 1999). Specific 
manuals for patients, physicians and nurses should be structured. Periodic evaluations 
should be planned, reviewing all procedures and discussing results and problems. 
4.4 Telemedicine global quality assessment 
A quality assessment plan should be available to control and monitor a telemedicine health 
care system. A system for automatically flagging and providing information on the results 
has to be structured specifically. In detail a telemedicine system for anticoagulated patients 
requires alerts on the following indicators: 
- control of coagulation testing; 
- time spent in therapeutic range for patient managed in AC versus peripheral health 
units; 
- number of controls for patients/year/peripheral health unit; 
- number of bleeding and thromboembolic complications (percent patient-years); 
- increase in patient attendance at the medical services provided by the peripheral health 
units resulting in a better distribution of workloads; 
- waiting times for access/blood drawing; 
- waiting times for therapeutic prescription; 
A patient’s satisfaction questionnaire has to be structured. 
5. A telemedicine Anticoagulation Clinic: An example of web organization 
In Italy from the beginning of 2001, some AC started telemedicine projects in different areas, 
interesting the following cities: Bologna, Cremona, Merano, Parma, Perugia. Even if these 
organizations differ in some aspects, like type of software used  and level of management, 
the general principle and aims are common. As an example we describe the experience of 
the Cremona Hospital. Cremona AC started its activity 20 years ago and in 2011 is 
managing about 4494 patients. In 2002 a project intended to define criteria for decentralizing 
the management of OAT patients in suburban health districts, through a telemedicine 
system, bi-directional connected was elaborated. Principal aims were to create a web 
organization in order to improve the quality of life of the patients living far from the AC 
site, maintaining the same clinical quality level. All procedures adopted are on controlled 
certified quality program. The INR is determined on capillary blood through portable 
monitors and the AC receives INR results with anamnestic questionnaire. Electronic medical 
record  includes information  upload on general clinical conditions, diet intake and drug co-
medication, INR and other laboratory data, general compliance and drug adherence, 
significant clinical events such as hospitalizations, surgery and invasive procedures. These 
data, collected in peripheral health care units (Nursing Homes, Groups of General 
Practitioners (GPs) and other hospitals of the area), are sent in real time to the AC,  in order 
to share bi-directionally all clinical records. Moreover, AC is able to manage home patients 
(who can not leave their home due to serious physical problems, diseases in progress, old 
age) through mobile units and totally independent patients who directly communicate 
through the web connection system with the AC (Fig. 4). 
11 peripheral health care units (2 Nursing Homes and 9 GP’s peripheral health units) and 20 
self-testing patients are currently connected for a total number of 1393 patients, i.e. 31% of 
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the total number of patients. 106 GPs and 22 nurses underwent training courses. As regard 
clinical quality indicators, no differences in time spent in the therapeutic range were 
observed between AC and GP’s units, while Nursing Homes showed, as expected because 
of sub-acute illnesses, the lower TTR (TTR AC=73%; TTR GP’s units=73.4%; TTR Nursing 
Homes=66%) (Tab. 5). No differences in major (haemorrhagic and/or thrombotic) 
complications were observed (Tab. 6).  
 
GPs
ANTICOAGULATION 
CLINICS
Nursing Homes
Other Peripheral
Health Care Units
PST/PSM  
Connections supported 
by internet technologies
 
Fig. 4. A model of web organization 
 
 % IN RANGE % UNDER 
RANGE 
% OVER 
RANGE 
INR > 4.5 (%) 
AC 73.7 % 21.5 4.8 0.2 
GPs 73.4 % 21.3 5.3 0.2 
Nursing Homes 66 % 24.2 9.8 0.6 
Table 5. Time spent in range: comparison between AC and Peripheral Health Units 
 
EVENTS AC Peripheral Units 
MAJOR BLEEDING 
(percent p/y) 
1.1 % 1.0 % 
THROMBOSIS 
(percent p/y) 
2.8 % 2.5 % 
MINOR BLEEDING 
(percent p/y) 
4.5 % 3.1 % 
Table 6. Clinical Quality 2010  
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All patients express their satisfaction, showing a general improvement in their quality of 
life. The development of this telemedicine organization facilitates patient access and reduces 
waiting times for patients and their relatives  as well as improves global quality of clinical 
assistance. The bi-directional informatic system used in this project is planned to set up the 
anticoagulated patient’s clinical record that is constantly updated and already structured to 
manage new anticoagulant drugs (Fig. 5).  
 
Anticoagulation Clinic
Thrombosis Haemostasis Center
PSM PST
Peripheral Districts (PD) / General Practitioner (GP)
Hospital Nursing Home
PD/GP PD/GP
Selection and training
Selection and training
 
Fig. 5. Bidirectional connection between AC and peripheral districts  
6. Limits in telemedicine development 
Several barriers can limit the development of telemedicine in health care system. Major 
difficulties are represented by differences among different countries and regions, due to 
legal, cultural and organizational problems. Informatic evolution technologies should solve 
problems in connectivity among different health care structures. Furthermore, the lack of 
clear regulations for telemedicine development still represents a limit, increasing the rate of 
uncertainty. A telemedicine system  have to guarantee a strict surveillance to avoid the 
potential lack of data and all unauthorized accesses. Health care telemedicine systems 
should be validated by experts, easy to use, flexible and adaptable in different clinical 
conditions.  Training for all health care staff on new technologies have to be provided before 
starting up telemedicine management. Clinical protocols and all procedures have to be 
shared and formally approved, waiting for institutional regulations.  
7. Conclusion 
One of the major problem in anticoagulation management is represented not only by the 
increasing number  of OAT patients as a result of ageing, but also by the extension of clinical 
indications and choice of the best management strategies to assure effectiveness and safety. 
Telemedicine systems are technologies that allow the development of new management 
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models in different medical fields (Klonoff, 2009). Telemedicine applied to anticoagulated 
patients offers several advantages, both for organization as well as for improving 
communications. Decentralize clinical activity through a telemedicine system give the 
opportunity to redistribute patient population into different health care areas, whose 
medical services could be otherwise underused, and to facilitate accessibility to health care 
services for an increased number of patients, empowering management strategies. At the 
same time the web creates the opportunity to export quality procedures and competences 
outside specialized centres, increasing communications, not only between physician and 
patient, but also between different medical specialties. Telemedicine organizations are 
opportunities to improve health care and patient’s quality of life through a capillary 
distribution of medical assistance, supporting physicians in the application of good clinical 
practice in anticoagulation management and in providing the following actions : 
 properly define indications  
 avoid treatment in patients who have major controindications 
 stop therapy when advantages are less than risks 
 identify drug and food interactions 
 provide educational courses for patients and relatives 
 determine a proper periodical control of anticoagulation level 
 prescribe the right daily drug dose 
 manage complications 
 define protocols for patients undergoing invasive procedure or surgery 
 periodically verify clinical and analytical  performances 
Telemedicine systems should help physicians to ensure the above mentioned items in order 
to give the best quality of management and avoid malpractice. The mainstay of this model 
relies on its extreme flexibility and that it can be adopted by either nursing care facilities, 
such as nursing homes, or healthcare facilities equipped with a medical staff, than by 
hospitals or groups of general practitioners. Moreover, it may help patients who cannot 
attend AC because of work-related reasons or remote location (patients on self-testing or 
self-management) or for those who cannot leave their homes because of chronic illness. As 
regard clinical quality, telemedicine system provide a very high quality comparable to the 
best standard and it can allow a reduction of health care costs through a more effective 
patient management compared to RMC. The service’s accessibility represents probably the 
best advantage, giving to all patients the opportunity to be managed with a good clinical 
quality. Telemedicine represents an improvement in equity of health care  and should be 
empowered by the government of different countries (Clark et al., 2010). The bidirectional 
computer connection allow peripheral health units to directly communicate with References 
structures, like AC or other specialists, creating electronic clinical chart constantly updated. 
Because of anticoagulant drugs are changing in the last few years and will rapidly change in 
the next future, through the introduction of new antithrombotic drugs, telemedicine could 
help the management.  Informatic connections represent the starting point of a telemedicine 
system that will enable healthcare providers to monitor patients either on OAT or treated 
with new classes of anticoagulants (low molecular weight heparins, fondaparinux, 
idraparinux, dabigatran, rivaroxaban, apixaban or other new oral factor II or factor X 
inhibitors, etc). Probably, the new-generation antithrombotic drugs will need different types 
of management compared with AVKs, with a less frequent clinical and laboratory control. 
Nevertheless it will be necessary to follow up and record patient’s data to guarantee the 
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strict quality control on adherence, compliance,  time in the therapeutic range, incidence of 
intercurrent diseases, adverse events and complications. Telemedicine can also support, in 
the next future, phamacovigilance procedures, usefull to improve knowledge on all new 
drugs (adverse events, major and minor complications, potentially dangerous drug 
interactions). However, notwithstanding these advantages due to telemedicine 
organizations, periodical clinical evaluations will be mandatory in order to assess any 
disease progression or changes in individual bleeding/thromboembolic risks. For these 
reasons a direct interactive communication between general practitioners and medical 
specialists is necessary and a telemedicine model will prove to be very useful, facilitating 
contacts and reporting. Health Authorities should promote telemedicine development with 
the aim to favour web organization for anticoagulation among different structures and 
specialists like Anticoagulation Clinics,  General Practitioners or others. A web telemedicine 
organization have to assure the adoption of certification procedures to guarantee the quality 
of management and pharmacovigilance reports for the different anticoagulant drugs. The 
advantage of a web organization can be summarized as following: 
- accessibility for a higher number of patients to a high quality management system; 
- integration among different specialists and health structures  
- continuing medical record update; 
- possibility to manage patients on different antithrombotic drugs. 
The web give the possibility to rapidly increase connections modulating the management in 
relation to different molecules, assuring clinical control for all patients.  
It’s advisable the empowerment of telemedicine strategies in routine clinical practice, 
through informatic programs suitable for each type of anticoagulant and patient, to favour a 
global management. 
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